µCPC…

• … improves the outflow of aqueous humor to rebalance the IOP
• … is a non-destructive procedure with the aim of shrinking the ciliary muscle
• … shows a success rate of up to 95 %, mean value ~ 80 %
• … shows an IOP reduction of up to 45 %, mean value ~ 38 %
• … offers you a treatment method with a low risk of inflammation compared to CPC
• … is a safe and effective treatment with a very low side effect profile for lowering intraocular pressure
• … is safe and effective without long-term side effects
• … reduces the need for glaucoma medication by an average of 40%
• … can be used at an earlier stage of glaucoma than conventional CPCs
• … is repeatable, even up to 3 treatments are no problem for your patient